Menu
Recruiting NCT07349251

Normal Hemostasis Values in Premature Infants

— Observational Premature Infant, Hemostasis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Premature Infant, Hemostasis. Basic parameters: 0 months — 18 months · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.

Primary outcome measures

  • Normal hemostasis values in premature infants [Time frame: Up to 6 years]

Eligibility criteria

Inclusion criteria

  • Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter

Exclusion criteria

  • Patients with incomplete data
  • Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

France · 1 center
  • Laboratoire d'Hématologie - CHU de Strasbourg - France — Strasbourg

Identifiers

NCT: NCT07349251 · 9948

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗